Luisa Casadei

Prof. Dr. Luisa Casadei


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2013 in Gynecological Endocrinology
Verified
Journal Article
Closed access
PDF file
LCLuisa Casadei
Luisa Casadei
AMAlessandra Madrigale
Alessandra Madrigale
FPFrancesco Puca
Francesco Puca
CMClaudia Manicuti
Claudia Manicuti
EEEmanuela Emidi
Emanuela Emidi
DDDidier Dewailly
Didier Dewailly
Background: The study was performed to validate the threshold for anti-Müllerian hormone (AMH) that suggests the presence of polycystic ovaries in women with polycystic ovary syndrome (PCOS). Methods: This prospective observational study included 59 infertile women: (A) 22 PCOS with hyperandrogenism (HA) and oligo-anovulation, (B) 15 suspected PCOS with either HA or oligo-anovulation and (C) 22 asymptomatic control women. The diagnosis of PCOS was made according to the NIH classification. Results: For serum AMH and follicle number, respectively, the areas under the receiver operating characteristic curve (A versus C) were 0.97 and 0.93. The best compromise between specificity (95% and 91%) and sensitivity (95% and 82%) was obtained with threshold values of 33 pmol/l and 13 follicles, respectively. Using a serum AMH > 33 pmol/l as a surrogate for either HA or oligo-anovulation in group B would lead to the diagnosis of PCOS in seven (46.6%) patients from this group. Conclusions: Our data confirms that the AMH assay has a high diagnostic potential, providing that an appropriate threshold is used. AMH measurement may be included as an ultimate diagnostic criterion for the diagnosis of PCOS when either HA or anovulation is missing and/or when no reliable antral follicle count can be obtained.

1 July 2010 in Fertility and Sterility
Verified
Journal Article
Closed access
LCLuisa Casadei
Luisa Casadei
FPFrancesco Puca
Francesco Puca
LPLaura Privitera
Laura Privitera
VZValentina Zamaro
Valentina Zamaro
EEEmanuela Emidi
Emanuela Emidi

25 May 2018 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
LCLuisa Casadei
Luisa Casadei
FFFrancesca Fanisio
Francesca Fanisio
RSRoberto Pietro Sorge
Roberto Pietro Sorge
MCMatteo Collamarini
Matteo Collamarini
EPEleonora Piccolo
Eleonora Piccolo
EPEmilio Piccione
Emilio Piccione

1 December 2006 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
LCLuisa Casadei
Luisa Casadei
VZValentina Zamaro
Valentina Zamaro
MCMonica Calcagni
Monica Calcagni
CTCarlo Ticconi
Carlo Ticconi
MDMaria Dorrucci
Maria Dorrucci
EPEmilio Piccione
Emilio Piccione

1 January 2016 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
LCLuisa Casadei
Luisa Casadei
EPEleonora Piccolo
Eleonora Piccolo
CMClaudia Manicuti
Claudia Manicuti
SCSilvia Cardinale
Silvia Cardinale
MCMatteo Collamarini
Matteo Collamarini
EPEmilio Piccione
Emilio Piccione
Casadei L, et al. Obstet Gynecol Sci. 2016 May;59(3):220-226. http://dx.doi.org/10.5468/ogs.2016.59.3.220

4 May 2018 in Gynecological Endocrinology
Verified
Journal Article
Closed access
LCLuisa Casadei
Luisa Casadei
FDFrancesca Dominici
Francesca Dominici
DSDoriana Scaldaferri
Doriana Scaldaferri
VVVeronica Vicomandi
Veronica Vicomandi
SCSusanna Ciacci
Susanna Ciacci
EPEmilio Piccione
Emilio Piccione
This prospective study had the objective to compare anti-Müllerian hormone (AMH) serum levels among women with endometriomas and those with other benign ovarian cysts and verify a possible correlation between the AMH post-operative decline and the achievement of pregnancy. The study included 57 women undergoing laparoscopic surgery. Serum levels of AMH were measured preoperatively and at 6 and 12 months postoperatively. AMH serum levels decreased in both endometriomas and other benign cysts, but significant recovery was reported only in endometriomas (p = .029). Through an interview, information on reproductive outcome was obtained. The secondary endpoint was to identify other predictors of spontaneous pregnancy onset. After surgery 27 women attempted to conceive. At 18-months follow-up, 12 of them got pregnant, with a live birth of 37%. We did not record statistically significant differences in reproductive outcome between women with AMH serum levels lower and higher than 1.1 ng/ml (41.7 and 53.3% respectively). There was no statistically significant difference in AMH serum levels between pregnant and non-pregnant women, neither before nor after surgery. AMH did not appear to have a predictive role on reproductive outcome.